Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse. Increased noradrenaline in the brain has long been implicated in opiate withdrawal, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of beta-noradrenergic-receptor antagonists, or of an alpha2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, the stress-induced reinstatement of drug-related responding in animal models appears to depend on the activation of both CRF and norepinephrine in elements of the extended amygdala (ie, central nucleus of the amygdala and bed nucleus of the stria terminalis; tables 1, 2, circuits 16 and 17)22,33,53,96–98 and the ventral tegmental area (tables 1, 2, circuit 9).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
In the citing paper
“As tolerance and withdrawal develop, brain stress systems, such as CRF, norepinephrine, and dynorphin, are recruited in the extended amygdala and contribute to the development of negative emotional states in withdrawal and protracted abstinence (tables 1, 2, circuits 6–8).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
Citations
Cites
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Paxinos, G. (1985) · Cited by 3,715
Clonidine blocks acute opiate-withdrawal symptoms
Gold, M., Redmond, D. E., & Kleber, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92823-4 · Cited by 710
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Pothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · cited 1×
“Increased noradrenaline during opiate withdrawal has also been linked to decreased dopamine in the NA”
BackgroundSchulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285
The Lower Brainstem and Bodily Homeostasis
Loewy, A. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01234-x · Cited by 260
The Lower Brainstem and Bodily Homeostasis
Blessing, W. W. (1997) · Cited by 254
Tejani-Butt, S. M. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11249-4 · Cited by 239
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
Self-citation
Research works printed but not linked: 2
- Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).
- McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).
Cited by
Items 301–400 of 491
Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome
McGregor, R., Wu, M., Holmes, B., Lam, H. A., Maidment, N. T., Gera, J., Yamanaka, A., & Siegel, J. M. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1557-21.2021 · Cited by 23
Timing of Morphine Administration Differentially Alters Paraventricular Thalamic Neuron Activity
McDevitt, D. S., & Graziane, N. (2019) · eNeuro · doi:10.1523/eneuro.0377-19.2019 · Cited by 23
Moriyama, A., Nishizawa, D., Kasai, S., Hasegawa, J., Fukuda, K., Nagashima, M., Katoh, R., & Ikeda, K. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12159fp · Cited by 23
Cai, L. X., Bakalli, H., & Rinaman, L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.008 · Cited by 23
Olsen, C. M., Huang, Y., Goodwin, S., Ciobanu, D. C., Lu, L., Sutter, T. R., & Winder, D. G. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00224.2006 · Cited by 22
Deyama, S., Ide, S., Kondoh, N., Yamaguchi, T., Yoshioka, M., & Minami, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.023 · Cited by 22
Erb, S. M., Lopak, V., & Smith, C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.012 · Cited by 22
Valero, E., Gómez-Milanés, I., Almela, P., Couto, B. R. D., Laorden, M. L., Milanés, M. V., & Núñez, C. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.018 · Cited by 22
Criner, S. H., Liu, J., & Schulteis, G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.002 · Cited by 22
Immune challenge activates neural inputs to the ventrolateral bed nucleus of the stria terminalis
Bienkowski, M. S., & Rinaman, L. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.03.006 · Cited by 22
Glass, M. J., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.10036 · Cited by 22
Neonatal Animal Models of Opiate Withdrawal
Richardson, K. A., Yohay, A.-L., Gauda, E. B., & McLemore, G. L. (2006) · ILAR Journal · doi:10.1093/ilar.47.1.39 · Cited by 22
Rasmussen, K., & Vandergriff, J. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00296-4 · Cited by 22
Aldosterone-sensitive neurons in the nucleus of the solitary: efferent projections.
Geerling, J. C., & LOEWY, A. (2006) · PubMed · Cited by 22
Sun, J. J., & Ray, R. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159474 · Cited by 21
Noradrenergic Signaling Disengages Feedforward Transmission in the Nucleus Accumbens Shell
Manz, K. M., Coleman, B. C., Grueter, C. A., Shields, B. C., Tadross, M. R., & Grueter, B. A. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2420-20.2021 · Cited by 21
Naka, T., Ide, S., Nakako, T., Hirata, M., Majima, Y., Deyama, S., Takeda, H., Yoshioka, M., & Minami, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.021 · Cited by 21
Falconnier, C., Caparros-Roissard, A., Decraene, C., & Lutz, P.-É. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02238-1 · Cited by 20
Narp regulates long-term aversive effects of morphine withdrawal.
Reti, I. M., Crombag, H. S., Takamiya, K., Sutton, J. M., Guo, N., Dinenna, M. L., Huganir, R. L., Holland, P. C., & Baraban, J. M. (2008) · Behavioral Neuroscience · doi:10.1037/a0012514 · Cited by 20
Ross, J. A., & Bockstaele, E. J. V. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14714 · Cited by 20
Erb, S. M., Funk, D. R., Borkowski, S., Watson, S. J., & Akil, H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.031 · Cited by 20
Zarrindast, M.-R., Homayoun, H., Khavandgar, S., & Fayaz-Dastgerdi, M. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200203000-00003 · Cited by 20
Baidoo, N., Wolter, M., Holahan, M. R., Epp, T., Winters, B. D., & Leri, F. (2020) · Addiction Biology · doi:10.1111/adb.12909 · Cited by 19
Zaragoza, J. N., Laorden, M. L., & Milanés, M. V. (2015) · Addiction Biology · doi:10.1111/adb.12328 · Cited by 19
Mantamadiotis, T., Schütz, G., & Maldonado, R. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_2 · Cited by 19
Bedard, M. L., Lord, J. S., Perez, P. J., Bravo, I. M., Teklezghi, A. T., Tarantino, L. M., Diering, G. H., & McElligott, Z. A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114441 · Cited by 18
Bockstaele, E. J. V., Rudoy, C., Mannelli, P., Oropeza, V. C., & Qian, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20738 · Cited by 18
Caillé, S., Rodríguez‐Arias, M., Miñarro, J., Fernández‐Espejo, E., Cador, M., & Stinus, L. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.5.995 · Cited by 18
Caillé, S., Stinus, L., Fernández‐Espejo, E., Deurwaerdère, P. D., Spampinato, U., & Koob, G. F. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300033 · Cited by 18
Lin, E. R.-H., Veenker, F., Manza, P., Yonga, M.-V., Abey, S. K., Wang, G., & Volkow, N. D. (2024) · Brain Sciences · doi:10.3390/brainsci14121285 · Cited by 17
Legastelois, R., Darcq, E., Wegner, S. A., Lombroso, P. J., & Ron, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127408 · Cited by 17
Carboni, E., & Carta, A. R. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2105144 · Cited by 17
Hedges, D. M., Yorgason, J. T., Brundage, J., Wadsworth, H. A., Williams, B. M., Steffensen, S. C., & Roberto, M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108293 · Cited by 17
Solecki, W., Kuś, N., Gralec, K., Klasa, A., Pradel, K., & Przewłocki, R. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.041 · Cited by 16
Morisot, N., & Contarino, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.021 · Cited by 16
Seip, K. M., Reed, B., Zhang, Y., Ho, A., & Kreek, M. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2801-2 · Cited by 16
Region-specific mechanisms for testosterone-induced Fos in hamster brain
Nagypál, A., & Wood, R. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.022 · Cited by 16
Georges, F. E., Caillé, S., Vouillac‐Mendoza, C., Moine, C. L., & Stinus, L. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04356.x · Cited by 16
Javelle, N., B�rod, A., Renaud, B., & ̃as, L. L. ́.-S. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00037 · Cited by 16
Soares, J. A. G., Sutley-Koury, S. N., Pomrenze, M. B., & Tucciarone, J. (2025) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1521016 · Cited by 15
Guerrin, C. G. J., Tesselaar, D. R. M., Booij, J., Schellekens, A., & Homberg, J. R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106311 · Cited by 15
Martín‐Sánchez, F., Núñez, C., Marín, M. T., Laorden, M. L., Kovács, K., & Milanés, M. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031119 · Cited by 15
Ayrancı, G., Befort, K., Lalanne, L., Kieffer, B. L., & Lutz, P.-É. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3826-5 · Cited by 15
Tong, J., Hornykiewicz, O., Furukawa, Y., & Kish, S. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04636.x · Cited by 15
Increased opioid dependence in a mouse model of panic disorder
Gallego (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.060.2009 · Cited by 15
Zajda, M., Krząścik, P., Hill, M., & Majewska, M. D. (2012) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2012-1881 · Cited by 14
Jonkman, S., & Markou, A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.030 · Cited by 14
The corticotropin-releasing factor receptor-2 mediates the motivational effect of opiate withdrawal
Rouibi, K., & Contarino, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.011 · Cited by 14
Brain stress system response after morphine-conditioned place preference
García-Carmona, J. A., Milanés, M. V., & Laorden, M. L. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000588 · Cited by 14
Noradrenaline Modulates Central Amygdala GABA Transmission and Alcohol Drinking in Female Rats
Anjos-Santos, A., Erikson, C. M., Flores‐Ramirez, F. J., Rodriguez, L., Barchiesi, R., Vozella, V., Borgonetti, V., Cruz, B., Zalfa, C., Hughes, K. J., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.03.024 · Cited by 13
Morisot, N., Rouibi, K., & Contarino, A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.49 · Cited by 13
Ciriello, J., Caverson, M. M., & Li, Z.-S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.032 · Cited by 13
Ishida, S., Shimosaka, R., Kawasaki, Y., Jin, C., Kitamura, Y., Araki, H., Sendo, T., & Gomita, Y. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.395 · Cited by 13
Jones, K. L., & Barr, G. A. (2000) · Synapse · doi:10.1002/1098-2396(200102)39:2<139::aid-syn5>3.0.co;2-# · Cited by 13
Zaragoza, J. N., Laorden, M. L., & Milanés, M. V. (2014) · Toxicology · doi:10.1016/j.tox.2014.10.002 · Cited by 12
The Brain Epinephrine-α1-Adrenoceptor System in Behavioral Activation and Depression
Stone, E., & Quartermain, D. (2005) · Current Psychiatry Reviews · doi:10.2174/1573400052953565 · Cited by 12
Azadi, M., Gompf, H. S., & Azizi, H. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120953993 · Cited by 11
Fox, M. E., Bucher, E. S., Johnson, J. A., & Wightman, R. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00210 · Cited by 11
Nagai, M. M., Gomes, F. V., Crestani, C. C., Resstel, L. B. M., & Joca, S. R. L. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283618ae4 · Cited by 11
Parkitna, J. M. R., Solecki, W., Gołembiowska, K., Tokarski, K., Kubik, J., Gołda, S., Novak, M., Parlato, R., Hess, G., Sprengel, R., et al. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001568 · Cited by 11
Ide, S., Yamamoto, R., Takeda, H., & Minami, M. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12004 · Cited by 11
Neurobiological Theories of Addiction
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50046-1 · Cited by 11
VTA µ-Opioidergic Neurons Facilitate Low Sociability in Protracted Opioid Abstinence
Jo, A. Y., Xie, Y., Wooldridge, L. M., Rogers, S. A., Kimmey, B. A., Rodrigues, A., Ortega, R. A. S., Creasy, K. T., Beier, K. T., Blendy, J. A., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1154-24.2025 · Cited by 10
Kanai, M., Kamiizawa, R., HitoraーImamura, N., & Minami, M. (2021) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2021.103157 · Cited by 10
Zhao, Z., Kim, S. C., Jiao, Y., Wang, Y., Lee, B. H., Kim, H. Y., Lee, C. W., Yang, C. H., & Zhao, R. (2021) · Behavioural Neurology · doi:10.1155/2021/2149371 · Cited by 10
Animal Models of Drug Dependence: Motivational Perspective
Koob, G. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_15 · Cited by 10
Antioxidant Properties of Adrenaline in the Presence of Ge‐132
Filonova, G. E., Nikolaevskaya, E. N., Kansuzyan, A. V., Krylova, I. V., Egorov, M. P., Jouikov, V., & Syroeshkin, M. A. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900331 · Cited by 10
King’uyu, D. N., Edgar, E. L., Figueroa, C., Kirkland, J. M., & Kopec, A. M. (2024) · Behavioral Neuroscience · doi:10.1037/bne0000567 · Cited by 9
Wilson, M. A., & McDonald, A. J. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-815134-1.00008-8 · Cited by 9
Hunt, S. P., & Urch, C. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50028-x · Cited by 9
Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal
Olson, V. G., Griner, N. B., Heusner, C. L., & Palmiter, R. D. (2006) · Synapse · doi:10.1002/syn.20328 · Cited by 8
Analysis of the source of aggressiveness in gamecocks
Komiyama, T., Yoshikawa, M., Yokoyama, K., & Kobayashi, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-63961-1 · Cited by 8
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50041-2 · Cited by 8
Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 8
Mechanisms Regulating Compulsive Drug Behaviors
Werner, C. T., Gancarz, A. M., & Dietz, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00010-5 · Cited by 8
Sibbach, B. M., Karim, H. T., Lo, D., Kasibhatla, N. P., Santini, T., Weber, J. C., Ibrahim, T. S., & Banihashemi, L. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02713-z · Cited by 7
Nebraska Symposium on Motivation, Volume 50: Motivational Factors in the Etiology of Drug Abuse
Bevins, R. A., & Bardo, M. T. (2004) · Project Muse (Johns Hopkins University) · Cited by 7
Rapid Detox: Understanding New Treatment Approaches for the Addicted Patient
McCabe, S. (2009) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2000.tb00599.x · Cited by 7
A Review of Relapse in Opioid Use Disorder
Draghmeh, K., Gold, M. S., & Fuehrlein, B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00672-5 · Cited by 6
Raitiere, M. N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.847584 · Cited by 6
Park, S.-H., Sim, Y., Kang, Y., Kim, C.-H., Kwon, M., & Suh, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.010 · Cited by 6
Neurocircuitry of Mindfulness-Based Interventions for Substance Use Prevention and Recovery
Kirlić, N., Cohen, Z. P., & Stewart, J. L. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00396-2 · Cited by 6
Shen, G., Yang, S., Wu, L., Chen, Y., Hu, Y., Zhou, F., Wang, W., Liu, P., Wu, F., Liu, Y., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1085429 · Cited by 6
Shining light on the noradrenergic system
Tanguay, E., Bouchard, S.-J., Lévesque, M., Koninck, P. D., & Breton‐Provencher, V. (2023) · Neurophotonics · doi:10.1117/1.nph.10.4.044406 · Cited by 6
Baidoo, N., & Leri, F. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109018 · Cited by 6
OPIATES: ACTION MECHANISMS, METABOLISM AND RELATION WITH THE NEONATAL ABSTINENCE SYNDROME
Osório, J. H. (2009) · Repositorio Universidad de Caldas · Cited by 6
García-Carmona, J. A., Laorden, E. M., Milanés, M. V., & Laorden, M. L. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.01.002 · Cited by 6
Sensitization to morphine withdrawal in guinea-pigs
Mizutani, A., Arvidsson, J., & Chahl, L. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.043 · Cited by 6
Rasmussen, K. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-306-4_22 · Cited by 6
A final common pathway for depression: implications for therapy
Stone, E. A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.1019 · Cited by 6
Dexmedetomidine potently and reversibly regulates stress-mediated behaviors
Yocca, F. D., Dhull, D. K., Seth, S., Chugh, M., Sharma, S., Nandabalan, K., Postma, F. R., & Vivo, M. D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1589075 · Cited by 5
McNair, E. M., Dawkins, L., Materia, B. R., Ross, G., Barnett, A., Nakkala, P., Qin, L., Zou, J., Nikolova, V. D., Moy, S. S., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.10.005 · Cited by 5
The Role of Norepinephrine in Drug Addiction: Past, Present, and Future
Foster, S. L., & Weinshenker, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00015-4 · Cited by 5
Zhu, K., Tao, G., Huang, Z., Qu, W., & Wang, L. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16068 · Cited by 5
Smoking Related Changes in Neurotransmitters in African Americans
Mishra, S., Mandal, A., & Mandal, P. K. (2011) · Journal of Bioprocessing & Biotechniques · doi:10.4172/2155-9821.1000e106 · Cited by 5
Ketamine blocks morphine-induced conditioned place preference and anxiety-like behaviors in micePreprint
McKendrick, G., Garrett, H., Jones, H. E., McDevitt, D. S., Sharma, S., Silberman, Y., & Graziane, N. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.22.915728 · Cited by 5
Arakaki, S., & Minami, M. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12252 · Cited by 4
Kaufman, M. J., & Meloni, E. G. (2025) · Medical Gas Research · doi:10.4103/mgr.medgasres-d-24-00063 · Cited by 4
Monoamine Transporters in Drugs of Abuse: Insights from Fast Scan Cyclic Voltammetry
Samels, S. B., Yüksel, P., & España, R. A. (2025) · Advances in neurobiology · doi:10.1007/978-3-031-96364-3_7 · Cited by 4
Central amygdalar PKCδ neurons mediate fentanyl withdrawal
Wooldridge, L. M., Wu, J. W. K., Jo, A. Y., Zinn, M., Lee, A. M., Mahmood, M., Cohen, S. A., McCall, N. M., Oswell, C. S., Rogers, S. A., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02298-7 · Cited by 4
Metadata
- Authors
- Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G.
- Affiliations
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
- Venue
- Nature
- Published
- 2000-01
- Volume
- 403
- Issue
- 6768
- Pages
- 430-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1659240124
- Semantic Scholar
- 973cb279566f11006ae21f697af863157189bf18
- Cited by
- 462
- References
- 31
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 3 · 2023: 16 · 2022: 12 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 11 · 2016: 12 · 2015: 18 · 2014: 8 · 2013: 18 · 2012: 24
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- norepinephrine, opioid withdrawal, conditioned place aversion, bed nucleus of the stria terminalis, caudal medulla, noradrenergic projections, alpha-2 adrenergic agonists, locus coeruleus, ventral forebrain, aversive conditioning
- MeSH terms
- Adrenergic alpha-Agonists, Adrenergic beta-Antagonists, Amygdala, Animals, Clonidine, Male, Narcotics, Neurons, Afferent, Norepinephrine, Propanolamines, Propranolol, Substance Withdrawal Syndrome, Tyrosine 3-Monooxygenase, Betaxolol, Prosencephalon, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.